AC, P., JM, R., MBA, D., AM, B., & AJ, S. (2026). Comparison of Subcutaneous Versus Intramuscular Estradiol Administration for Feminizing Gender-Affirming Hormone Therapy. Pharmacy (Basel, Switzerland), 14(1), . https://doi.org/10.3390/pharmacy14010013
Chicago Style (17th ed.) CitationAC, Poage, Rowe JM, Dameron MBA, Bavuso AM, and Smith AJ. "Comparison of Subcutaneous Versus Intramuscular Estradiol Administration for Feminizing Gender-Affirming Hormone Therapy." Pharmacy (Basel, Switzerland) 14, no. 1 (2026). https://doi.org/10.3390/pharmacy14010013.
MLA (9th ed.) CitationAC, Poage, et al. "Comparison of Subcutaneous Versus Intramuscular Estradiol Administration for Feminizing Gender-Affirming Hormone Therapy." Pharmacy (Basel, Switzerland), vol. 14, no. 1, 2026, https://doi.org/10.3390/pharmacy14010013.